STAFF

Christine Cole

Senior Director, Head of Philanthropy & Partnerships

Erica Mawby-Roche

Senior Director of Programs

Dan Ouellette

Programs Manager

Ageena Peterson

Operations & Office Manager

Catharine Smith

Executive Director

Lorie Umanita

Administrative Coordinator

Susan Clark

Assistant to President & Co-Founder, Belinda Termeer

BOARD OF DIRECTORS

Paul Hastings

Member of the Board of Directors; President and CEO, Nkarta Therapeutics and Chair of the Board, Biotechnology Innovation Organization (BIO)

Gail Maderis

Member of the Board of Directors; President and CEO of Antiva Biosciences, member of the Board of Directors at Valitor Inc., the Biotechnology Innovation Organization (BIO), and the California Life Sciences Institute

John Maraganore

Mentor and Member of the Board of Directors; CEO and Director at Alnylam Pharmaceuticals, Chair of the Board for Agios Pharmaceuticals, co-chair of the Termeer Tribute Committee, and member of the Biotechnology Innovation Organization (BIO) Executive Committee.

Alice Pomponio

Member of the Board of Directors; Managing Director of BrightEdge and Vice President of Innovation and Impact Investing at the American Cancer Society, Board Observer at NAVERIS, and Board Observer at Vincere Health. 

Joan Reede, M.D.

Member of the Board of Directors; Dean for Diversity and Community Partnership at Harvard Medical School, President of the Biomedical Science Careers Program.

Belinda Termeer

President, Co-Founder and Member of the Board of Directors; Head of the Termeer family office; member of the Board of Directors of PIC Therapeutics, the Board of Fellows and the Discovery Committee at Harvard Medical School, the President’s Council at Massachusetts General Hospital, the Board of Directors of Celebrity Series of Boston, the leadership council of the Silent Spring Institute, and the Women in Science and Engineering Committee at the Museum of Science; Trustee Emerita of the Boston Ballet

Alan Walts

Treasurer, Secretary, Mentor, Co-Founder and Member of the Board of Directors; Venture Partner with Advent Life Sciences, Executive Chairman of PIC Therapeutics and Artax Biopharma, Board Member of Eloxx Pharmaceuticals and Neuroelectrics Corp, Board Observer at Amylyx Pharmaceuticals and Arrakis Therapeutics, Advisory Board Member of the ALS Investment Fund

Mentors

Jeff Albers

Executive Chairman of the Board of Directors, Blueprint Medicines

Jens Bitsch-Norhave

Vice President of Transaction & Innovation Partnering, Johnson & Johnson Innovation

Mike Bonney

Executive Chair, Kaleido

Katharine Bowdish

President & CEO, PIC Therapeutics

John Butler

President & CEO, Akebia

Josh Cohen

Co-CEO & Co-Founder, Amylyx Pharmaceuticals

Daniel de Boer

Founder & CEO, ProQR

Elisabet de los Pinos

Founder & CEO, Aura Biosciences

Deborah Dunsire, M.D.

President & CEO, H. Lundbeck A/S

Mark Enyedy

President & CEO, ImmunoGen

Paul Fonteyne

Executive in Residence, Canaan Partners

Jim Geraghty

Board Director & Chair, Healthcare Leader

Michael Gilman

CEO, Arrakis Therapeutics

Tom Graney

CEO, Oxurion NV

Paul Hastings

CEO, Nkarta Therapeutics

Kate Haviland

CEO, Blueprint Medicines

Marie-Louise Hovgaard Sveen

Head of US R&D Operations, Novo Nordisk

Colin Hill

Co-Founder and CEOAitia

Ed Kaye

CEO, Stoke Therapeutics

Justin Klee

Co-CEO & Co-Founder, Amylyx Pharmaceuticals

Art Krieg

Founder, President & CEOZola Therapeutics

Alison Lawton

Special Advisor to Office of CEO,
Kaleido Biosciences

Juan Carlos Lopez

Managing Director, RTW Charitable Foundation

John Maraganore

Former Founding CEO, Alnylam

Kristina Masson

Co-Founder and Executive Vice President of Business Operations, Acrivon Therapeutics Inc. President and CEO, Acrivon AB

Tom Mathers

Founder, President & CEO,
Allievex Corporation

Geoff McDonough

President & CEO, Generation Bio

David Meeker

Chairman, President & CEO,
Rhythm Therapeutics

Lydia Meyer-Turkson

Head of North American Public Private PartnershipsPhillips

Ann Miller, M.D.

Member Board of Directors, Inovio Pharmaceuticals, Puma Biotechnology, and Allena Pharmaceuticals

Mike Minogue

Chairman, President & CEO, Abiomed

Richard Moscicki

Former Executive Vice President for Science and Regulatory Advocacy & Chief Medical Officer, Pharmaceutical Research and Manufacturers of America (PhRMA)

Masako Nakamura

Global Biotech Executive

Imran Nasrullah

VP & Head, Collaborate2Cure Hub, US, BD&LBayer

Paula Ragan

CEO, X4 Pharmaceuticals

Bart Scheerder

Business Developer of Data Driven InnovationUMCG Innovation Center

Hans Schikan

Top Team Member, Health Holland

Alicia Secor

President & CEO, Atalanta Therapeutics

Craig Shimasaki

Co-Founder & CEO, Moleculera Labs

Paula Soteropoulos

Chairwoman of the Board, Ensoma

Dinko Valerio

Scientist-turned-Entrepreneur

Willem van Weperen

Senior Commercial Leader

Alan Walts

Treasurer, Secretary, Board of Directors,
The Termeer Foundation

Gene Williams

Chairman and Co-FounderProMIS™ Neurosciences, Inc.

Troy Wilson

President and CEOKura Oncology, Inc.

Peter Wirth

Venture Partner, Quan Capital Management

James Xue

Founder, Chairman & CEO,
CANbridge Pharmaceuticals

Andrey Zarur

 Founder & CEO, GreenLight Biosciences, Inc.

Advisors

Sun Altbach

Lindsay Androski

Mark Levin

Trista Morrison